level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Dr. Francesco R.に依頼
Canada

Scientific Writer & Data Analyst | Expertise in Research Support, Data Visualization & Presentation Creation

プロフィール概要
専門分野
サービス
Writing Medical Writing, Non-Medical Regulatory Writing, Technical Writing, Creative Writing, General Proofreading & Editing
Research Meta-Research, Fact Checking, Gap Analysis, Scientific and Technical Research, Systematic Literature Review
Consulting Healthcare Consulting, Scientific and Technical Consulting
Data & AI Statistical Analysis, Image Analysis, Data Visualization, Big Data Analytics
職務経験

Postdoctorate

University Health Network, Toronto, Canada

3月 2024 - 3月 2025

Postdoctorate

University of Rome Tor Vergata

2月 2022 - 3月 2024

PhD Fellow

University of Rome Tor Vergata

11月 2018 - 2月 2022

学歴

PhD Molecular Biology

University of Roma "Tor Vergata" - Italy

11月 2018 - 2月 2022

認定資格
  • Scientific Writing for Research Grant Proposals

    University of Colorado

    3月 2025 - 現在

  • Design and Interpretation of Clinical Trials

    John Hopkins University

    3月 2025 - 現在

  • Excel for Data Analysis

    IBM

    2月 2025 - 現在

  • Introduction to Data Analytics

    IBM

    2月 2025 - 現在

  • ICH GOOD CLINICAL PRACTICE

    The Global Health Network

    2月 2025 - 現在

出版物
JOURNAL ARTICLE
E. Foffi, A. Violante, R. Pecorari, A. M. Lena, F. Rugolo, G. Melino, E. Candi (2024). BRD4 sustains p63 transcriptional program in keratinocytes . Biology Direct.
Manuela Montanaro, Massimiliano Agostini, lucia anemona, Elena Bonanno, Francesca Servadei, Enrico Finazzi Agrò, Anastasios D. Asimakopoulos, Carlo Ganini, Chiara Cipriani, Marta Signoretti, et al. (2023). ZNF750: A Novel Prognostic Biomarker in Metastatic Prostate Cancer . International Journal of Molecular Sciences.
Francesco Rugolo, Nicolas G. Bazan, Jorgelina Calandria, Bokkyoo Jun, Giuseppe Raschellà, Gerry Melino, Massimiliano Agostini (2022). Correction to: The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome . Oncogene.
Francesco Rugolo, Nicolas G. Bazan, Jorgelina Calandria, Bokkyoo Jun, Giuseppe Raschellà, Gerry Melino, Massimiliano Agostini (2021). The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome . Oncogene.
Francesco Rugolo and Nicolas G. Bazan and Jorgelina Calandria and Bokkyoo Jun and Giuseppe Raschell{\`{a}} and Gerry Melino and Massimiliano Agostini(2021). The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome . Oncogene. 40. (38). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 5741--5751. Springer Science and Business Media {LLC}
Alessio Butera and Matteo Cassandri and Francesco Rugolo and Massimiliano Agostini and Gerry Melino(2020). The ZNF750–RAC1 axis as potential prognostic factor for breast cancer . Cell Death Discovery. 6. (1). Springer Science and Business Media {LLC}